Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Dowell JA

Collect these papers and discover other ones on Labmeeting. Learn more.

Rat brain neuropeptidomics: tissue collection, protease inhibition, neuropeptide extraction, and mass spectrometric analysis.

+ cite this

+ View Abstract

Sturm RM, Dowell JA, and Li L

Methods in molecular biology (Clifton, N.J.) 615:217-26, 2010 - Who cited this? | PubMed ID: 20013212 | Fulltext

Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics.

+ cite this

+ View Abstract

Dowell JA, Johnson JA, and Li L

Journal of proteome research 8(8):4135-43, 2009 Aug - Who cited this? | PubMed ID: 19469553 | Fulltext

Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment.

+ cite this

+ View Abstract

Marbury T, Dowell JA, Seltzer E, and Buckwalter M

Journal of clinical pharmacology 49(4):465-76, 2009 Apr - Who cited this? | PubMed ID: 19318696 | Fulltext

In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome p450 interactions of anidulafungin.

+ cite this

+ View Abstract

Damle BD, Dowell JA, Walsky RL, Weber GL, Stogniew M, and Inskeep PB

Antimicrobial agents and chemotherapy 53(3):1149-56, 2009 Mar - Who cited this? | PubMed ID: 19029327 | Fulltext

The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease.

+ cite this

+ View Abstract

Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, and Johnson JA

Antioxidants & redox signaling 11(3):497-508, 2009 Mar - Who cited this? | PubMed ID: 18717629 | Fulltext

Mass spectrometric characterization of neuropeptides.

+ cite this

+ View Abstract

Cape SS, Dowell JA, and Li L

Methods in molecular biology (Clifton, N.J.) 492:381-93, 2009 - Who cited this? | PubMed ID: 19241046 | Fulltext

Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic.

+ cite this

+ View Abstract

Dowell JA, Goldstein BP, Buckwalter M, Stogniew M, and Damle B

Journal of clinical pharmacology 48(9):1063-8, 2008 Sep - Who cited this? | PubMed ID: 18633123 | Fulltext

Comparison of Two-Dimensional Fractionation Techniques for Shotgun Proteomics.

+ cite this

+ View Abstract

Dowell JA, Frost DC, Zhang J, and Li L

Analytical chemistry, 2008 Aug 5 - Who cited this? | PubMed ID: 18680313 | Fulltext

Population pharmacokinetic modeling of epoetin delta in pediatric patients with chronic kidney disease.

+ cite this

+ View Abstract

Knebel W, Palmen M, Dowell JA, and Gastonguay M

Journal of clinical pharmacology 48(7):837, 2008 Jul - Who cited this? | PubMed ID: 18490498 | Fulltext

Pharmacokinetics of dalbavancin in plasma and skin blister fluid.

+ cite this

+ View Abstract

Nicolau DP, Sun HK, Seltzer E, Buckwalter M, and Dowell JA

The Journal of antimicrobial chemotherapy 60(3):681-4, 2007 Sep - Who cited this? | PubMed ID: 17631507 | Fulltext

Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbits.

+ cite this

+ View Abstract

Solon EG, Dowell JA, Lee J, King SP, and Damle BD

Antimicrobial agents and chemotherapy 51(8):3008-10, 2007 Aug - Who cited this? | PubMed ID: 17548492 | Fulltext

Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.

+ cite this

+ View Abstract

Smith WB, Dowell JA, and Pratt RD

Clinical therapeutics 29(7):1368-80, 2007 Jul - Who cited this? | PubMed ID: 17825688 | Fulltext

Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment.

+ cite this

+ View Abstract

Dowell JA, Stogniew M, Krause D, and Damle B

Journal of clinical pharmacology 47(4):461-70, 2007 Apr - Who cited this? | PubMed ID: 17389555 | Fulltext

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

+ cite this

+ View Abstract

Dowell JA, Stogniew M, Krause D, Henkel T, and Damle B

Journal of clinical pharmacology 47(3):305-14, 2007 Mar - Who cited this? | PubMed ID: 17322142 | Fulltext

Rat neuropeptidomics by LC-MS/MS and MALDI-FTMS: Enhanced dissection and extraction techniques coupled with 2D RP-RP HPLC.

+ cite this

+ View Abstract

Dowell JA, Heyden WV, and Li L

Journal of proteome research 5(12):3368-75, 2006 Dec - Who cited this? | PubMed ID: 17137338 | Fulltext

Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.

+ cite this

+ View Abstract

Benjamin DK, Driscoll T, Seibel NL, Gonzalez CE, Roden MM, Kilaru R, Clark K, Dowell JA, Schranz J, and Walsh TJ

Antimicrobial agents and chemotherapy 50(2):632-8, 2006 Feb - Who cited this? | PubMed ID: 16436720 | Fulltext

Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.

+ cite this

+ View Abstract

Dowell JA, Schranz J, Baruch A, and Foster G

Journal of clinical pharmacology 45(12):1373-82, 2005 Dec - Who cited this? | PubMed ID: 16291712 | Fulltext

Population pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptide.

+ cite this

+ View Abstract

Buckwalter M and Dowell JA

Journal of clinical pharmacology 45(11):1279-87, 2005 Nov - Who cited this? | PubMed ID: 16239361 | Fulltext

Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine.

+ cite this

+ View Abstract

Dowell JA, Stogniew M, Krause D, Henkel T, and Weston IE

Journal of clinical pharmacology 45(2):227-33, 2005 Feb - Who cited this? | PubMed ID: 15647416 | Fulltext

Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia.

+ cite this

+ View Abstract

Buckwalter M, Dowell JA, Korth-Bradley J, Gorovits B, and Mayer PR

Journal of clinical pharmacology 44(8):873-80, 2004 Aug - Who cited this? | PubMed ID: 15286091 | Fulltext

Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal.

+ cite this

+ View Abstract

Dowell JA, Knebel W, Ludden T, Stogniew M, Krause D, and Henkel T

Journal of clinical pharmacology 44(6):590-8, 2004 Jun - Who cited this? | PubMed ID: 15145966 | Fulltext

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.

+ cite this

+ View Abstract

Seltzer E, Dorr MB, Goldstein BP, Perry M, Dowell JA, Henkel T, and Dalbavancin Skin and Soft-Tissue Infection Study Group

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 37(10):1298-303, 2003 Nov 15 - Who cited this? | PubMed ID: 14583862 | Fulltext

Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapse.

+ cite this

+ View Abstract

Berger MS, Leopold LH, Dowell JA, Korth-Bradley JM, and Sherman ML

Investigational new drugs 20(4):395-406, 2002 Nov - Who cited this? | PubMed ID: 12448657 | Fulltext

Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in first relapse.

+ cite this

+ View Abstract

Dowell JA, Korth-Bradley J, Liu H, King SP, and Berger MS

Journal of clinical pharmacology 41(11):1206-14, 2001 Nov - Who cited this? | PubMed ID: 11697753 | Fulltext

Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin.

+ cite this

+ View Abstract

Korth-Bradley JM, Dowell JA, King SP, Liu H, Berger MS, and Mylotarg Study Group

Pharmacotherapy 21(10):1175-80, 2001 Oct - Who cited this? | PubMed ID: 11601662 | Fulltext

Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.

+ cite this

+ View Abstract

Dowell JA, Korth-Bradley J, Milisci M, Tantillo K, Amorusi P, and Tse S

Journal of clinical pharmacology 41(9):979-86, 2001 Sep - Who cited this? | PubMed ID: 11549103 | Fulltext

Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors.

+ cite this

+ View Abstract

Dowell JA, Sancho AR, Anand D, and Wolf W

Advanced drug delivery reviews 41(1):111-26, 2000 Mar 15 - Who cited this? | PubMed ID: 10699308 | Fulltext

Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.

+ cite this

+ View Abstract

Dowell JA, Hussain A, Devane J, and Young D

Journal of pharmaceutical sciences 88(1):154-60, 1999 Jan - Who cited this? | PubMed ID: 9874718 | Fulltext

Validation of in vitro-in vivo correlation models.

+ cite this

Young D, Dowell JA, Piscitelli DA, and Devane J

Advances in experimental medicine and biology 423:87-91, 1997 - Who cited this? | PubMed ID: 9269485 | Fulltext

Development of in vitro-in vivo correlations using various artificial neural network configurations.

+ cite this

Dowell JA, Hussain AS, Stark P, Devane J, and Young D

Advances in experimental medicine and biology 423:225-39, 1997 - Who cited this? | PubMed ID: 9269500 | Fulltext

The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study.

+ cite this

+ View Abstract

Sancho AR, Dowell JA, and Wolf W

Cancer chemotherapy and pharmacology 40(6):521-5, 1997 - Who cited this? | PubMed ID: 9332467 | Fulltext

Search Google Scholar for Dowell JA

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.